Benralizumab (Fasenra)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 16:42, 27 May 2021 by Cafitts (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

No FDA approval for hematology/oncology conditions, at this time.

General information

Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).

Diseases for which it is used

Patient Drug Information

Also known as

  • Brand names: Fasenra

References

  1. ↑ Benralizumab (Fasenra) Package Insert
Retrieved from "https://hemonc.org/w/index.php?title=Benralizumab_(Fasenra)&oldid=50040"